UNITED24 - Make a charitable donation in support of Ukraine!

Homeland Security

Taiwan records 10 new COVID-19 cases; 240,000 Medigen slots reserved

ROC Central News Agency

08/16/2021 05:34 PM

Taipei, Aug. 16 (CNA) The Central Epidemic Command Center (CECC) said Monday that Taiwan recorded 10 new cases of COVID-19, and that over 240,000 people have made appointments to get a locally produced COVID-19 vaccine next week.

Of the new cases, eight were transmitted domestically and two were contracted overseas, Health and Welfare Minister Chen Shih-chung (陳時中) said at the CECC press briefing.

All of the domestic cases were reported in northern Taiwan, with six in New Taipei and one each in Taipei and Taoyuan. Health authorities have identified the infection source in six of these cases, and two are still under investigation, Chen said.

 


The two imported cases, meanwhile, involved a Taiwanese national and a Ghanaian national who recently traveled to Taiwan from the United States and Ghana, respectively, CECC spokesperson Chuang Jen-hsiang (莊人祥) said at the same briefing.

The Taiwanese national had been fully vaccinated against COVID-19, having received her second BioNTech-Pfizer shot in early July, and she has been asymptomatic so far, Chuang said.

To date, Taiwan has confirmed a total of 15,862 COVID-19 cases, of which 14,313 are domestic infections reported since May 15, when the country first recorded more than 100 COVID-19 cases in a single day.

With no new deaths reported for two consecutive days, the number of confirmed COVID-19 deaths in the country remained at 821, with all but 12 recorded since May 15, CECC data showed.

 


On the subject of vaccines, the CECC said that as of 1 p.m. Monday, 242,654 people had made appointments to get the locally produced COVID-19 vaccine made by Medigen Vaccine Biologics Corp. next week.

This amounts to 40 percent of the 605,359 people who are eligible to make reservations in the current round, the CECC said.

Those eligible are people 36 years old and over or those aged 20-25 who suffer from rare or serious illnesses or injuries who previously indicated their willingness to get the Medigen vaccine on the government's vaccination appointment website.

Bookings for the current round were opened on 10 a.m. Monday and will close at noon on Wednesday, according to the CECC.

A total of 614,204 doses produced by Medigen have passed inspection by Taiwan's Food and Drug Administration (FDA).

Medigen is the only domestic company to have received emergency use authorization (EUA) in Taiwan for its COVID-19 vaccine. The EUA application by another domestic company, United Biomedical Inc. Asia, was rejected by the FDA on Sunday.

The EUA was granted without Medigen having to perform a Phase 3 clinical trial to demonstrate its ability to protect users against the virus. Instead, it was approved based on the amount of antibodies it was able to generate in trial subjects.

To date, nearly 39 percent of Taiwan's 23.5 million population have received one COVID-19 vaccine shot, and 2.8 percent have received the two doses needed to be fully vaccinated.

(By Chiang Yi-ching)

Enditem/ls

 



Note: Taiwan's vaccine rollout began on March 22, first with doses from AstraZeneca, then with Moderna doses starting on June 9.



NEWSLETTER
Join the GlobalSecurity.org mailing list